As more aggressive treatment with the early use of combination treatment and insulin is recommended by the latest Clinical Practice Guidelines (CPG) for T2DM [18], this study was designed to examine the current management and glycemic control of T2DM patients seeking care at public health clinics across Kedah. The gene discussed is INS; the disease is type 2 diabetes mellitus.